Hypersensitivity vasculitis induced by terbutaline sulfate.
Hypersensitivity vasculitis developed in a patient six days after therapy with terbutaline sulfate was initiated. The casual association between the drug and hypersensitivity vasculitis is based on the temporal relationship, a positive lymphocyte transformation test with terbutaline sulfate, and exclusion of other causes. This is, to the best of our knowledge, the first report of a leukocytoclastic vasculitic reaction to terbutaline sulfate.
Enat
R
R
Department of Medicine, Rambam Medical Center, Technion-Israel Institute of Technology, Haifa.
Katz
R
R
Munichor
M
M
Pollack
S
S
D000368:Aged; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D013726:Terbutaline / Q000009:adverse effects*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced*
D013726:Terbutaline